105 related articles for article (PubMed ID: 16456383)
1. Use of theophylline in chronic obstructive pulmonary disease: examining the evidence.
Ram FS
Curr Opin Pulm Med; 2006 Mar; 12(2):132-9. PubMed ID: 16456383
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of theophylline in people with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Ram FS; Jardin JR; Atallah A; Castro AA; Mazzini R; Goldstein R; Lacasse Y; Cendon S
Respir Med; 2005 Feb; 99(2):135-44. PubMed ID: 15715180
[TBL] [Abstract][Full Text] [Related]
3. A comparison between inhaled salmeterol and theophylline in the short-term treatment of stable chronic obstructive pulmonary disease.
Broseghini C; Testi R; Polese G; Tosatto R; Rossi A
Pulm Pharmacol Ther; 2005; 18(2):103-8. PubMed ID: 15649852
[TBL] [Abstract][Full Text] [Related]
4. [Meta-analysis of efficacy and safety of oral theophylline in chronic obstructive pulmonary disease].
Wang CH; Zhang Q; Li M; Fu PF; Yan ZM; Peng AM; Zhang GL
Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(8):540-6. PubMed ID: 20367966
[TBL] [Abstract][Full Text] [Related]
5. Effect of theophylline associated with short-acting or long-acting inhaled beta2-agonists in patients with stable chronic obstructive pulmonary disease: a systematic review.
Zacarias EC; Castro AA; Cendon S
J Bras Pneumol; 2007; 33(2):152-60. PubMed ID: 17724534
[TBL] [Abstract][Full Text] [Related]
6. Plant-based formulation in the management of chronic obstructive pulmonary disease: a randomized double-blind study.
Murali PM; Rajasekaran S; Paramesh P; Krishnarajasekar OR; Vasudevan S; Nalini K; Lakshmisubramanian S; Deivanayagam CN
Respir Med; 2006 Jan; 100(1):39-45. PubMed ID: 15905081
[TBL] [Abstract][Full Text] [Related]
7. Tiotropium for stable chronic obstructive pulmonary disease: A meta-analysis.
Barr RG; Bourbeau J; Camargo CA; Ram FS
Thorax; 2006 Oct; 61(10):854-62. PubMed ID: 16844726
[TBL] [Abstract][Full Text] [Related]
8. Oral theophylline for chronic obstructive pulmonary disease.
Ram FS; Jones PW; Castro AA; De Brito JA; Atallah AN; Lacasse Y; Mazzini R; Goldstein R; Cendon S
Cochrane Database Syst Rev; 2002; 2002(4):CD003902. PubMed ID: 12519617
[TBL] [Abstract][Full Text] [Related]
9. [Theophylline in the treatment of chronic obstructive pulmonary disease: a randomized, double-blind, placebo-controlled study].
Zhou YM; Wang XP; Zeng XY; Qiu R; Xie JF; Liu SM; Zheng JP; Zhong NS; Ran PX
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Sep; 29(9):577-82. PubMed ID: 17129461
[TBL] [Abstract][Full Text] [Related]
10. Effects of theophylline on plasma levels of interleukin-4, cyclic nucleotides and pulmonary functions in patients with chronic obstructive pulmonary disease.
Zhang N; Xu Y; Zhang Z; Liu J; Fang H; Ni W
J Tongji Med Univ; 1999; 19(1):15-9. PubMed ID: 12840867
[TBL] [Abstract][Full Text] [Related]
11. [Effect of theophylline on respiratory function in patients with chronic obstructive lung disease].
Sooronbaev TM; Altymysheva AT; Shabykeeva SB; Kadyraliev ZhK; Mirrakhimov MM
Probl Tuberk Bolezn Legk; 2006; (7):13-6. PubMed ID: 16944706
[TBL] [Abstract][Full Text] [Related]
12. Methylxanthines for exacerbations of chronic obstructive pulmonary disease: meta-analysis of randomised trials.
Barr RG; Rowe BH; Camargo CA
BMJ; 2003 Sep; 327(7416):643. PubMed ID: 14500434
[TBL] [Abstract][Full Text] [Related]
13. The additive effect of theophylline on a combination of formoterol and tiotropium in stable COPD: a pilot study.
Cazzola M; Gabriella Matera M
Respir Med; 2007 May; 101(5):957-62. PubMed ID: 17056241
[TBL] [Abstract][Full Text] [Related]
14. Positive benefits of theophylline in a randomized, double-blind, parallel-group, placebo-controlled study of low-dose, slow-release theophylline in the treatment of COPD for 1 year.
Zhou Y; Wang X; Zeng X; Qiu R; Xie J; Liu S; Zheng J; Zhong N; Ran P
Respirology; 2006 Sep; 11(5):603-10. PubMed ID: 16916334
[TBL] [Abstract][Full Text] [Related]
15. Bu-Fei Yi-Shen granule combined with acupoint sticking therapy in patients with stable chronic obstructive pulmonary disease: a randomized, double-blind, double-dummy, active-controlled, 4-center study.
Li JS; Li SY; Yu XQ; Xie Y; Wang MH; Li ZG; Zhang NZ; Shao SJ; Zhang YJ; Zhu L; Guo LX; Bai YP; Wang YF
J Ethnopharmacol; 2012 Jun; 141(2):584-91. PubMed ID: 21911051
[TBL] [Abstract][Full Text] [Related]
16. Management of chronic obstructive pulmonary disease. Statement about theophyllines is misleading.
O'Driscoll BR
BMJ; 2003 Apr; 326(7393):821; author reply 821. PubMed ID: 12689985
[No Abstract] [Full Text] [Related]
17. Long-term treatment with theophylline reduces neutrophils, interleukin-8 and tumor necrosis factor-alpha in the sputum of patients with chronic obstructive pulmonary disease.
Iiboshi H; Ashitani J; Katoh S; Sano A; Matsumoto N; Mukae H; Nakazato M
Pulm Pharmacol Ther; 2007; 20(1):46-51. PubMed ID: 16413994
[TBL] [Abstract][Full Text] [Related]
18. A randomised, placebo-controlled, dose-finding study of AZD9668, an oral inhibitor of neutrophil elastase, in patients with chronic obstructive pulmonary disease treated with tiotropium.
Vogelmeier C; Aquino TO; O'Brien CD; Perrett J; Gunawardena KA
COPD; 2012 Apr; 9(2):111-20. PubMed ID: 22458939
[TBL] [Abstract][Full Text] [Related]
19. Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.
Boscia JA; Pudi KK; Zvarich MT; Sanford L; Siederer SK; Crim C
Clin Ther; 2012 Aug; 34(8):1655-66.e5. PubMed ID: 22789766
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of indacaterol in patients with chronic obstructive pulmonary disease aged over 65 years: A pooled analysis.
Girodet PO; Jasnot JY; Le Gros V; Decuypère L; Cao W; Devouassoux G
Respir Med; 2017 Jul; 128():92-101. PubMed ID: 28566230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
